| Absorption | 
      | Blood-Brain Barrier | BBB+ | 0.9371 | 
      | Human Intestinal Absorption | HIA+ | 0.7936 | 
      | Caco-2 Permeability | Caco2- | 0.5823 | 
      | P-glycoprotein Substrate | Non-substrate | 0.8753 | 
      | P-glycoprotein Inhibitor | Non-inhibitor | 0.9910 | 
                                                     | Non-inhibitor | 0.9925 | 
      | Renal Organic Cation Transporter | Non-inhibitor | 0.9574 | 
        
            | Distribution | 
        
      | Subcellular localization | Mitochondria | 0.7969 | 
        
          | Metabolism | 
        
      | CYP450 2C9 Substrate | Non-substrate | 0.8356 | 
      | CYP450 2D6 Substrate | Non-substrate | 0.8960 | 
      | CYP450 3A4 Substrate | Non-substrate | 0.7957 | 
      | CYP450 1A2 Inhibitor | Non-inhibitor | 0.8950 | 
      | CYP450 2C9 Inhibitor | Non-inhibitor | 0.9277 | 
        | CYP450 2D6 Inhibitor | Non-inhibitor | 0.9383 | 
      | CYP450 2C19 Inhibitor | Non-inhibitor | 0.9383 | 
      | CYP450 3A4 Inhibitor | Non-inhibitor | 0.9593 | 
      | CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9907 | 
        
          | Excretion | 
        
        
          | Toxicity | 
        
      | Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9615 | 
                                                                    | Non-inhibitor | 0.9881 | 
      | AMES Toxicity | Non AMES toxic | 0.9375 | 
      | Carcinogens | Non-carcinogens | 0.5568 | 
      | Fish Toxicity | High FHMT | 0.6584 | 
      | Tetrahymena Pyriformis Toxicity | Low TPT | 0.8996 | 
      | Honey Bee Toxicity | High HBT | 0.7956 | 
      | Biodegradation | Ready biodegradable | 0.9750 | 
      | Acute Oral Toxicity | III | 0.4808 | 
      | Carcinogenicity (Three-class) | Non-required | 0.7062 |